ScripAstellas Pharma. is deploying data analytics and cutting-edge technologies across its operations to inform better strategic business decisions and maximize value. In an interview with Scrip , Astell
ScripNew technologies like generative artificial intelligence (Gen AI) and digital-twins could potentially rewire the life sciences sector, with several promising use cases across the molecule-to-market co
Pink SheetIndian companies continued to seek new markets for mainstay generics in 2019, though the year also saw some early gains from an improved thrust into innovative R&D, alongside momentum in specialty and
ScripIndia delivered some hard-hitting rulings around intellectual property rights in the decade gone by, putting big pharma on the back foot at the time. The downward spiral of the Singh brothers, formerl